|
español |
|
|
|
|
||
![]() Click here to visit the pharmacy |
![]() |
![]() Click here to visit the pharmacy |
|||||||||
Some of the Indian Pharmacy prices: |
Some of the Worldwide Pharmacy prices: |
||||||||||
|
|
||||||||||
|
BEST SELLERS |
|||||||||||
|
INSOMNIA Ambien (brand name) and zolpidem (generic Ambien) |
TOO MUCH ACID IN STOMACH (ulcers, reflux disease - GERD or heartburn) Nexium (brand name) and esomeprazole (generic Nexium)Prevacid (brand name) and lansoprazole (generic Prevacid)Prilosec (brand name) and omeprazole (generic Prilosec)Protonix (brand name) and pantoprazole (generic Protonix)Zantac (brand name) and ranitidine (generic Zantac) |
||||||||||
|
MIGRAINES AND HEADACHES Imitrex (brand name) and sumatriptan (generic Imitrex) |
|||||||||||
|
FERTILITY Clomid (brand name) and clomiphene (generic Clomid) |
|||||||||||
|
NARCOLEPSY Modalert (brand name) and modafinil (generic Modalert) |
ERECTILE DYSFUNCTION (ED)- IMPOTENCE Viagra (brand name) and sildenafil citrate (generic Viagra) |
||||||||||
|
• Thu, Nov 20, 2008 -
FDA Approves New Drug to Treat Severe Form of Epilepsy. The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome. • Wed, Nov 12, 2008 - FDA Warns Public of Extortion Scam by FDA Impersonators. The U.S. Food and Drug Administration is warning consumers about a fraudulent scheme to extort money from consumers by callers who falsely identify themselves as "FDA special agents" or other FDA officials. • Thu, Nov 6, 2008 - FDA Seizes Contaminated Heparin from a Cincinnati Manufacturer. The five lots of Heparin Sodium Active Pharmaceutical Ingredient (API) and six lots of Heparin Lithium were seized at the FDA's request by U.S. Marshals. These products, which were manufactured from material imported from China, had been found by the agency to be contaminated with over-sulfated chondroitin sulfate (OSCS), a substance that mimics heparin's anticoagulant activity. • Wed, Nov 5, 2008 - FDA Reports Nationwide Recall of Mislabeled ReliOn Insulin Syringes. The U.S. Food and Drug Administration is notifying health care professionals and patients that Tyco Healthcare Group LP (Covidien) is recalling one lot of ReliOn sterile, single-use, disposable, hypodermic syringes with permanently affixed hypodermic needles due to possible mislabeling. The use of these syringes may lead to patients receiving an overdose of as much as 2.5 times the intended dose, which may lead to hypoglycemia, serious health consequences, and even death. |
• What are Generic Drugs? - FDA information about generic drugs
/
FDA Q&A about generic drugs |